The DOI matches its Crossref record; 248 of the 248 references it cites were found in a registry or an index.
Gonadotropin-Releasing Hormone Receptors
Open accessAbstract
GnRH and its analogs are used extensively for the treatment of hormone-dependent diseases and assisted reproductive techniques.They also have potential as novel contraceptives in men and women.A thorough delineation of the molecular mechanisms involved in ligand binding, receptor activation, and intracellular signal transduction is kernel to understanding disease processes and the development of specific interventions.Twenty-three structural variants of GnRH have been identified in protochordates and vertebrates.In many vertebrates, three GnRHs and three cognate receptors have been identified with distinct distributions and functions.In man, the hypothalamic GnRH regulates gonadotropin secretion through the pituitary GnRH type I receptor via activation of G q .In-depth studies have identified amino acid residues in both the ligand and receptor involved in binding, receptor activation, and translation into intracellular signal transduction.Although the predominant coupling of the type I GnRH receptor in the gonadotrope is through productive G q stimulation, signal transduction can occur via other G proteins and potentially by G protein-independent means.The eventual selection of intracellular signaling may be specifically directed by variations in ligand structure.A second form of GnRH, GnRH II, conserved in all higher vertebrates, including man, is present in extrahypothalamic brain and many reproductive tissues.Its cognate receptor has been cloned from various vertebrate species, including New and Old World primates.The human gene homolog of this receptor, however, has a frame-shift and stop codon, and it appears that GnRH II signaling occurs through the type I GnRH receptor.There has been considerable plasticity in the use of different GnRHs, receptors, and signaling pathways for diverse functions.Delineation of the structural elements in GnRH and the receptor, which facilitate differential signaling, will contribute to the development of novel interventive GnRH analogs.(Endocrine Reviews 25: 235-275, 2004) I. Introduction II.Structure of GnRHs and Analogs A. Structural variants of GnRHs B. Structure of GnRH and peptide analogs C. The evolutionarily conserved GnRH II D. Nonpeptide GnRH antagonists III.Structure of GnRH Receptors A. Primary structures of GnRH receptors B. Tertiary structure of the mammalian type I GnRH receptor IV.Binding of GnRH to the Mammalian Type I GnRH Receptor A. Aspartate 2.61(98) [D 2.61(98) ] B. Asparagine 2.65(102) [N 2.65(102) ] C. Lysine 3.32(121) [K 3.32(121) ] D. Asparagine 5.39(212) [N 5.39(212) ] E. Tyrosine 6.58(290) [Y 6.58(290) ] F. Aspartate 7.32(302) [D 7.32(302) ] G. Effects of mutations of other residues on the ligand binding pocket H. Ligand docking to the receptor V. Binding Interactions of Other GnRH Ligands and Other Receptors A. GnRH II B. Peptide agonists C. Peptide antagonists D. Nonpeptide antagonists E. Binding sites in nonmammalian type I GnRH receptors F. Binding sites in type II receptors G. Utilization of binding sites common to the rhodopsin family of GPCRs VI.Receptor Activation A. Interaction of Asn 2.50(87) /Asp 7.49(319) in TM 2/7 in GnRH receptor activation B. Disruption of TM3 Asp 3.49(138) /Arg 3.50(139) interaction in GnRH receptor activation C. The triad of Glu 2.53(90) -Lys 3.32(121) -Asp 2.61(98) D. Role of extracellular loop 2 E. Other residues possibly involved in receptor activation F. Integrated model of GnRH receptor activation VII.GnRH Receptor Mutations in Hypogonadotropic Hypogonadism VIII.Structural Correlates of GnRH Receptor Coupling and Internalization A. Coupling to multiple G proteins B. Regulators of G protein signaling (RGS) proteins C. GnRH receptor internalization IX. Conclusions and Future Perspectives I. Introduction G nRH IS THE central regulator of the reproductive hor- monal cascade and was first isolated from mammalian hypothalami as the decapeptide (pGlu-His-Trp-Ser-Tyr-
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–248 of 248
Protein Origami: Therapeutic Rescue of Misfolded Gene Products
Conn, P. M. (2002) · Molecular Interventions · doi:10.1124/mi.2.5.308 · Cited by 54
Weesner, G. D., & Matteri, R. L. (1994) · Journal of Animal Science · doi:10.2527/1994.7271911x · Cited by 54
Söderlund, D., Canto, P., de la Chesnaye, E., Ulloa‐Aguirre, A., & Méndez, J. P. (2001) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2001.01211.x · Cited by 53
Hövelmann, S., Hoffmann, S. H., Kühne, R., ter Laak, A., Reiländer, H., & Beckers, T. (2002) · Biochemistry · doi:10.1021/bi0113162 · Cited by 53
WORMALD, P. J., Eidne, K. A., & Millar, R. P. (1985) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-61-6-1190 · Cited by 52
Self-citationOkubo, K., Suetake, H., Usami, T., & Aida, K. (2000) · General and Comparative Endocrinology · doi:10.1006/gcen.2000.7511 · Cited by 52
Imai, A., Horibe, S., Takagi, A., & Tamaya, T. (1997) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(97)70501-5 · Cited by 51
Kottler, M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.9.3002 · Cited by 50
Deoraj, A., Hassin, S., Kumar, R. S., Trant, J. M., Yu, K.-L., & Zohar, Y. (2000) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(00)00317-8 · Cited by 49
Arora, K. K., Cheng, Z., & Catt, K. J. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.8.8843414 · Cited by 49
Pawson, A. J., Maudsley, S. R., Lopes, J., Katz, A. A., Sun, Y.-M., Davidson, J. S., & Millar, R. P. (2003) · Endocrinology · doi:10.1210/en.2003-0028 · Cited by 48
Self-citationThe conformational switch in 7-transmembrane receptors: the muscarinic receptor paradigm
Hulme, E. C., Lu, Z.-L., Ward, S. D. C., Allman, K., & CURTIS, C. A. M. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00297-6 · Cited by 48
Self-citationLayman, L. C., McDonough, P. G., Cohen, D., Maddox, M., Tho, S. P. T., & Reindollar, R. H. (2001) · Fertility and Sterility · doi:10.1016/s0015-0282(01)01782-4 · Cited by 47
Cui, J., Smith, R. G., Mount, G. R., Lo, J., Yu, J., Walsh, T. F., Singh, S. B., DeVita, R. J., Goulet, M. T., Schaeffer, J. M., et al. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.5.0464 · Cited by 47
LH-RH antagonists: design and synthesis of a novel series of peptidomimetics
De, B., Plattner, J. J., Bush, E. N., Jae, H.-S., Diaz, G. J., Johnson, E. S., & Perun, T. J. (1989) · Journal of Medicinal Chemistry · doi:10.1021/jm00129a003 · Cited by 45
Millar, R. P., Zhu, Y.-F., & Struthers, R. S. (2000) · British Medical Bulletin · doi:10.1258/0007142001903346 · Cited by 45
Self-citationSeong, J. Y., Wang, L., Oh, D. Y., Yun, O., Maiti, K., Li, J. H., Soh, J. M., Choi, H. S., Kim, K., Vaudry, H., et al. (2003) · Endocrinology · doi:10.1210/en.2002-220683 · Cited by 44
Advances in understanding gonadotrophin-releasing hormone receptor structure and ligand interactions
Flanagan, C. A. (1997) · Reviews of Reproduction · doi:10.1530/revreprod/2.2.113 · Cited by 44
Self-citationShinitzky, M., & Fridkin, M. (1976) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(76)90043-x · Cited by 40
Pfleger, K. D. G., Bogerd, J., & Millar, R. P. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0159 · Cited by 40
Self-citationTwo Mutations in Extracellular Loop 2 of the Human GnRH Receptor Convert an Antagonist to an Agonist
Ott, T. R., Troskie, B. E., Roeske, R. W., Illing, N., Flanagan, C. A., & Millar, R. P. (2002) · Molecular Endocrinology · doi:10.1210/me.16.5.1079 · Cited by 39
Self-citationMilton, R. C. D. L., King, J. S., Badminton, M. N., Tobler, C. J. P., Lindsey, G. G., Fridkin, M., & Millar, R. P. (1983) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(83)91410-9 · Cited by 37
Self-citationHormonal Male Contraception: A Real Chance?
Nieschlag, E., Behre, H. M., & Weinbauer, G. F. (1992) · Springer eBooks · doi:10.1007/978-3-662-02815-5_20 · Cited by 36
Behavioral Regulation of Gonadotropin-Releasing Hormone Production
Rissman, E. F., Li, X., King, J. A., & Millar, R. P. (1997) · Brain Research Bulletin · doi:10.1016/s0361-9230(97)00226-8 · Cited by 35
Self-citationJanovick, J. A., & Conn, P. M. (1993) · Endocrinology · doi:10.1210/endo.132.5.8386609 · Cited by 35
Tucci, F. C., Zhu, Y., Guo, Z., Gross, T. D., Connors, P. J., Struthers, R. S., Reinhart, G. J., Wang, X., Saunders, J., & Chen, C. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00745-x · Cited by 34
Delahaye, R., Manna, P. R., Bérault, A., Berreur‐Bonnenfant, J., Berreur, P., & Counis, R. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(97)00194-9 · Cited by 32
Poulin, B., Rich, N. J., Mas, J.-L., Kordon, C., Enjalbert, A., & Drouva, S. V. (1998) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(98)00114-2 · Cited by 32
Awara, W. M., Guo, C. H., & Conn, P. M. (1996) · Endocrinology · doi:10.1210/en.137.2.655 · Cited by 31
Acharjee, S., Maiti, K., Soh, J. M., Im, W., Seong, J. Y., & Kwon, H. B. (2002) · Molecules and Cells · doi:10.1016/s1016-8478(23)15079-5 · Cited by 31
Davidson, J. S., Flanagan, C. A., Davies, P. D., Hapgood, J. P., Myburgh, D. B., Elario, R., Millar, R. P., Forrest‐Owen, W., & McArdle, C. A. (1996) · Endocrine · doi:10.1007/bf02738686 · Cited by 28
Self-citationChauvin, S., Bérault, A., Lerrant, Y., Hibert, M., & Counis, R. (2000) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)26430-0 · Cited by 28
Cloning and gene expression of a novel human ribonucleoprotein
Conklin, D., Rixon, M. W., Kuestner, R. E., Maurer, M. F., Whitmore, T. E., & Millar, R. P. (2000) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(00)00090-7 · Cited by 25
Self-citationCastro-Fernández, C., & Conn, P. M. (2002) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(02)00082-5 · Cited by 23
Clinical Applications of Gonadotropin-Releasing Hormones in Reproductive Disorders
Moghissi, K. S. (1992) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30235-4 · Cited by 22
Petry, R., Craik, D. J., Haaima, G., Fromme, B. J., KLUMP, H. H., Kiefer, W., Palm, D., & Millar, R. P. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm011036k · Cited by 21
Self-citationMyburgh, D. B., Pawson, A. J., Davidson, J. S., Flanagan, C. A., Millar, R. P., & Hapgood, J. P. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1390438 · Cited by 20
Self-citationDifferential orientation of a GnRH agonist and antagonist in the pituitary GnRH receptor.
Janovick, J. A., Haviv, F., Fitzpatrick, T. D., et al. (1993) · Endocrinology · doi:10.1210/endo.133.2.8393780 · Cited by 19
Jagerschmidt, A., Guillaume, N., Roques, B. P., & Noble, F. (1998) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)13254-3 · Cited by 19
Design of Potent Dicyclic (4−10/5−8) Gonadotropin Releasing Hormone (GnRH) Antagonists
Rivier, J., Struthers, R. S., Porter, J., Lahrichi, S. L., Jiang, G., Cervini, L. A., Ibea, M., Kirby, D. A., Koerber, S. C., & RIVIER, C. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990115h · Cited by 18
Chung, H.-O., Yang, Q., Catt, K. J., & Arora, K. K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.50.35756 · Cited by 18
Luthin, D. R., Hong, Y., Pathak, V. P., Paderes, G. D., Nared-Hood, K., Castro, M. A., Vazir, H. N., Li, H., Tompkins, E., Christie, L. C., et al. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00755-2 · Cited by 18
Design of Potent Dicyclic (1−5/4−10) Gonadotropin Releasing Hormone (GnRH) Antagonists
Rivier, J., Jiang, G., Struthers, R. S., Koerber, S. C., Porter, J. R., Cervini, L. A., Kirby, D. A., Craig, A. G., & RIVIER, C. L. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm990116+ · Cited by 15
Gonadotropin‐Releasing Hormones and Their Receptors in Fish
Goos, H. J. T., Blomenröhr, M., Bogerd, J., Bosma, P. T., Li, K. W., Okuzawa, K., Rebers, F. E. M., Schulz, R. W., TENSEN, C. P., & Zandbergen, M. A. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10730.x · Cited by 14
Lin, X., Janovick, J. A., & Conn, P. M. (1998) · Biology of Reproduction · doi:10.1095/biolreprod59.6.1470 · Cited by 12
Assefa, D., Pawson, A. J., McArdle, C. A., Millar, R. P., Flanagan, C. A., Roeske, R. W., & Davidson, J. S. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00123-9 · Cited by 10
Self-citationBertherat, J. Y. (1998) · European Journal of Endocrinology · doi:10.1530/eje.0.1380621 · Cited by 10
Chauvin, S., Hibert, M., Bérault, A., & Counis, R. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(01)00675-x · Cited by 9
Cited by
Mammalian G Proteins and Their Cell Type Specific Functions
Wettschureck, N., & Offermanns, S. (2005) · Physiological Reviews · doi:10.1152/physrev.00003.2005 · Cited by 1,166
Perspectives on fish gonadotropins and their receptors
Levavi-Sivan, B., Bogerd, J., Mañanós, E. L., Gómez, A., & Lareyre, J. J. (2010) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2009.07.019 · Cited by 589
Zebrafish as an animal model for biomedical research
Choi, T.-Y., Choi, T.-I., Lee, Y.-R., Choe, S.-K., & Kim, C.-H. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00571-5 · Cited by 563
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Self-citationSmall Bioactive Peptides for Biomaterials Design and Therapeutics
Hamley, I. W. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00522 · Cited by 461
Metadata
- Authors
- Millar, R. P., Lu, Z.-L., Pawson, A. J., Flanagan, C. A., Morgan, K., & Maudsley, S. R.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-04-01
- Volume
- 25
- Issue
- 2
- Pages
- 235-275
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2141582604
- Cited by
- 794
- References
- 248
- FWCI
- 52.87
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.